[English] 日本語
Yorodumi- EMDB-46655: Cryo-EM structure of partially open HIV-1 BG505 SOSIP.664 Env bou... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of partially open HIV-1 BG505 SOSIP.664 Env bound to 3-sCD4, 3-17b Fab and 3-VRC34.01 Fab, Population 1 | |||||||||
Map data | HIV-1 BG505 SOSIP.664 Env bound to 3-sCD4, 3-17b Fab and 3-VRC34.01 Fab | |||||||||
Sample |
| |||||||||
Keywords | Recombinantly purified HIV-1 Env / sCD4 / 17b Fab and VRC34.01 Fab / viral Env / vaccine / VIRAL PROTEIN / VIRAL PROTEIN-IMMUNE SYSTEM complex | |||||||||
| Function / homology | Function and homology informationhelper T cell enhancement of adaptive immune response / interleukin-16 binding / interleukin-16 receptor activity / response to methamphetamine hydrochloride / maintenance of protein location in cell / cellular response to ionomycin / T cell selection / MHC class II protein binding / positive regulation of kinase activity / interleukin-15-mediated signaling pathway ...helper T cell enhancement of adaptive immune response / interleukin-16 binding / interleukin-16 receptor activity / response to methamphetamine hydrochloride / maintenance of protein location in cell / cellular response to ionomycin / T cell selection / MHC class II protein binding / positive regulation of kinase activity / interleukin-15-mediated signaling pathway / cellular response to granulocyte macrophage colony-stimulating factor stimulus / positive regulation of monocyte differentiation / Nef Mediated CD4 Down-regulation / Alpha-defensins / regulation of T cell activation / response to vitamin D / extracellular matrix structural constituent / Other interleukin signaling / T cell receptor complex / enzyme-linked receptor protein signaling pathway / Translocation of ZAP-70 to Immunological synapse / Phosphorylation of CD3 and TCR zeta chains / positive regulation of protein kinase activity / regulation of calcium ion transport / positive regulation of calcium ion transport into cytosol / macrophage differentiation / Generation of second messenger molecules / immunoglobulin binding / T cell differentiation / Co-inhibition by PD-1 / Binding and entry of HIV virion / coreceptor activity / positive regulation of plasma membrane raft polarization / positive regulation of receptor clustering / positive regulation of T cell proliferation / positive regulation of interleukin-2 production / positive regulation of calcium-mediated signaling / cell surface receptor protein tyrosine kinase signaling pathway / protein tyrosine kinase binding / host cell endosome membrane / Vpu mediated degradation of CD4 / clathrin-coated endocytic vesicle membrane / calcium-mediated signaling / positive regulation of protein phosphorylation / MHC class II protein complex binding / transmembrane signaling receptor activity / Downstream TCR signaling / Cargo recognition for clathrin-mediated endocytosis / response to estradiol / signaling receptor activity / Clathrin-mediated endocytosis / virus receptor activity / response to ethanol / defense response to Gram-negative bacterium / clathrin-dependent endocytosis of virus by host cell / adaptive immune response / positive regulation of viral entry into host cell / early endosome / cell surface receptor signaling pathway / positive regulation of ERK1 and ERK2 cascade / positive regulation of canonical NF-kappaB signal transduction / cell adhesion / positive regulation of MAPK cascade / viral protein processing / immune response / membrane raft / endoplasmic reticulum lumen / fusion of virus membrane with host plasma membrane / external side of plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / lipid binding / symbiont entry into host cell / endoplasmic reticulum membrane / protein kinase binding / positive regulation of DNA-templated transcription / virion attachment to host cell / host cell plasma membrane / virion membrane / structural molecule activity / enzyme binding / signal transduction / protein homodimerization activity / zinc ion binding / identical protein binding / membrane / plasma membrane Similarity search - Function | |||||||||
| Biological species | ![]() Human immunodeficiency virus 1 / Homo sapiens (human) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.91 Å | |||||||||
Authors | Thakur B / Acharya P | |||||||||
| Funding support | United States, 2 items
| |||||||||
Citation | Journal: Nat Commun / Year: 2025Title: Conformational trajectory of the HIV-1 fusion peptide during CD4-induced envelope opening. Authors: Bhishem Thakur / Revansiddha H Katte / Wang Xu / Katarzyna Janowska / Salam Sammour / Rory Henderson / Maolin Lu / Peter D Kwong / Priyamvada Acharya / ![]() Abstract: The hydrophobic fusion peptide (FP), a critical component of the HIV-1 entry machinery, is located at the N terminus of the envelope (Env) gp41 subunit. The receptor-binding gp120 subunit of Env ...The hydrophobic fusion peptide (FP), a critical component of the HIV-1 entry machinery, is located at the N terminus of the envelope (Env) gp41 subunit. The receptor-binding gp120 subunit of Env forms a heterodimer with gp41. The gp120/gp41 heterodimer assembles into a homotrimer, in which FP is accessible for antibody binding. Env conformational changes or "opening" that follow receptor binding result in FP relocating to a newly formed interprotomer pocket at the gp41-gp120 interface where it is sterically inaccessible to antibodies. The mechanistic steps connecting the entry-related transition of antibody accessible-to-inaccessible FP configurations remain unresolved. Here, using SOSIP-stabilized Env ectodomains, we visualize that the FP remains accessible for antibody binding despite substantial receptor-induced Env opening. We delineate stepwise Env opening from its closed state to a functional CD4-bound symmetrically open Env in which we show that FP was accessible for antibody binding. We define downstream re-organizations that lead to the formation of a gp120/gp41 cavity into which the FP buries to become inaccessible for antibody binding. These findings improve our understanding of HIV-1 entry and delineate the entry-related conformational trajectory of a key site of HIV vulnerability to neutralizing antibody. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_46655.map.gz | 117.8 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-46655-v30.xml emd-46655.xml | 28.4 KB 28.4 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_46655_fsc.xml | 10.6 KB | Display | FSC data file |
| Images | emd_46655.png | 98.4 KB | ||
| Filedesc metadata | emd-46655.cif.gz | 7.8 KB | ||
| Others | emd_46655_half_map_1.map.gz emd_46655_half_map_2.map.gz | 115.7 MB 115.7 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-46655 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-46655 | HTTPS FTP |
-Validation report
| Summary document | emd_46655_validation.pdf.gz | 845.8 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_46655_full_validation.pdf.gz | 845.3 KB | Display | |
| Data in XML | emd_46655_validation.xml.gz | 19.2 KB | Display | |
| Data in CIF | emd_46655_validation.cif.gz | 24.7 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-46655 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-46655 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9d90MC ![]() 9d8yC ![]() 9d98C C: citing same article ( M: atomic model generated by this map |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_46655.map.gz / Format: CCP4 / Size: 125 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | HIV-1 BG505 SOSIP.664 Env bound to 3-sCD4, 3-17b Fab and 3-VRC34.01 Fab | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 1.08 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #2
| File | emd_46655_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #1
| File | emd_46655_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : A Complex of ectodomain of HIV-1 BG505 SOSIP.664 Env with sCD4, 1...
| Entire | Name: A Complex of ectodomain of HIV-1 BG505 SOSIP.664 Env with sCD4, 17b Fab and VRC34.01 Fab |
|---|---|
| Components |
|
-Supramolecule #1: A Complex of ectodomain of HIV-1 BG505 SOSIP.664 Env with sCD4, 1...
| Supramolecule | Name: A Complex of ectodomain of HIV-1 BG505 SOSIP.664 Env with sCD4, 17b Fab and VRC34.01 Fab type: complex / ID: 1 / Parent: 0 / Macromolecule list: #3-#7 |
|---|---|
| Molecular weight | Theoretical: 300 KDa |
-Macromolecule #1: Surface protein gp120
| Macromolecule | Name: Surface protein gp120 / type: protein_or_peptide / ID: 1 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() Human immunodeficiency virus 1 |
| Molecular weight | Theoretical: 52.508406 KDa |
| Recombinant expression | Organism: Mammalia (mammals) |
| Sequence | String: NLWVTVYYGV PVWKDAETTL FCASDAKAYE TEKHNVWATH ACVPTDPNPQ EIHLENVTEE FNMWKNNMVE QMHTDIISLW DQSLKPCVK LTPLCVTLQC TNVTNNITDD MRGELKNCSF NMTTELRDKK QKVYSLFYRL DVVQINENQG NRSNNSNKEY R LINCNTSA ...String: NLWVTVYYGV PVWKDAETTL FCASDAKAYE TEKHNVWATH ACVPTDPNPQ EIHLENVTEE FNMWKNNMVE QMHTDIISLW DQSLKPCVK LTPLCVTLQC TNVTNNITDD MRGELKNCSF NMTTELRDKK QKVYSLFYRL DVVQINENQG NRSNNSNKEY R LINCNTSA ITQACPKVSF EPIPIHYCAP AGFAILKCKD KKFNGTGPCP SVSTVQCTHG IKPVVSTQLL LNGSLAEEEV MI RSENITN NAKNILVQFN TPVQINCTRP NNNTRKSIRI GPGQAFYATG DIIGDIRQAH CNVSKATWNE TLGKVVKQLR KHF GNNTII RFANSSGGDL EVTTHSFNCG GEFFYCNTSG LFNSTWISNT SVQGSNSTGS NDSITLPCRI KQIINMWQRI GQAM YAPPI QGVIRCVSNI TGLILTRDGG STNSTTETFR PGGGDMRDNW RSELYKYKVV KIEPLGVAPT RCKR UniProtKB: Envelope glycoprotein gp160 |
-Macromolecule #2: Transmembrane protein gp41
| Macromolecule | Name: Transmembrane protein gp41 / type: protein_or_peptide / ID: 2 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() Human immunodeficiency virus 1 |
| Molecular weight | Theoretical: 16.733998 KDa |
| Recombinant expression | Organism: Mammalia (mammals) |
| Sequence | String: AVGIGAVFLG FLGAAGSTMG AASMTLTVQA RNLLSGIVQQ QSNLLRAPEA QQHLLKLTVW GIKQLQARVL AVERYLRDQQ LLGIWGCSG KLICCTNVPW NSSWSNRNLS EIWDNMTWLQ WDKEISNYTQ IIYGLLEESQ NQQEKNEQDL UniProtKB: Envelope glycoprotein gp160 |
-Macromolecule #3: VRC34.01 heavy chain
| Macromolecule | Name: VRC34.01 heavy chain / type: protein_or_peptide / ID: 3 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 23.797615 KDa |
| Recombinant expression | Organism: Mammalia (mammals) |
| Sequence | String: QEVLVQSGAE VKKPGASVKV SCRAFGYTFT GNALHWVRQA PGQGLEWLGW INPHSGDTTT SQKFQGRVYM TRDKSINTAF LDVTRLTSD DTGIYYCARD KYYGNEAVGM DVWGQGTSVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV T VSWNSGAL ...String: QEVLVQSGAE VKKPGASVKV SCRAFGYTFT GNALHWVRQA PGQGLEWLGW INPHSGDTTT SQKFQGRVYM TRDKSINTAF LDVTRLTSD DTGIYYCARD KYYGNEAVGM DVWGQGTSVT VSSASTKGPS VFPLAPSSKS TSGGTAALGC LVKDYFPEPV T VSWNSGAL TSGVHTFPAV LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK KVEPK |
-Macromolecule #4: VRC34.01 light chain
| Macromolecule | Name: VRC34.01 light chain / type: protein_or_peptide / ID: 4 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 23.138766 KDa |
| Recombinant expression | Organism: Mammalia (mammals) |
| Sequence | String: DIQLTQSPSF LSASVGDKVT ITCRASQGVR NELAWYQQKP GKAPNLLIYY ASTLQSGVPS RFSATGSGTH FTLTVSSLQP EDFATYFCQ HMSSYPLTFG GGTKVEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS ...String: DIQLTQSPSF LSASVGDKVT ITCRASQGVR NELAWYQQKP GKAPNLLIYY ASTLQSGVPS RFSATGSGTH FTLTVSSLQP EDFATYFCQ HMSSYPLTFG GGTKVEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS Q ESVTEQDS KDSTYSLSST LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRG |
-Macromolecule #5: T-cell surface glycoprotein CD4
| Macromolecule | Name: T-cell surface glycoprotein CD4 / type: protein_or_peptide / ID: 5 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 20.129896 KDa |
| Recombinant expression | Organism: Mammalia (mammals) |
| Sequence | String: KKVVLGKKGD TVELTCTASQ KKSIQFHWKN SNQIKILGNQ GSFLTKGPSK LNDRADSRRS LWDQGNFPLI IKNLKIEDSD TYICEVEDQ KEEVQLLVFG LTANSDTHLL QGQSLTLTLE SPPGSSPSVQ CRSPRGKNIQ GGKTLSVSQL ELQDSGTWTC T VLQNQKKV EFKIDIVVLA FQK UniProtKB: T-cell surface glycoprotein CD4 |
-Macromolecule #6: 17b Fab light chain
| Macromolecule | Name: 17b Fab light chain / type: protein_or_peptide / ID: 6 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 23.399898 KDa |
| Recombinant expression | Organism: Mammalia (mammals) |
| Sequence | String: DIVMTQSPAT LSVSPGERAT LSCRASESVS SDLAWYQQKP GQAPRLLIYG ASTRATGVPA RFSGSGSGAE FTLTISSLQS EDFAVYYCQ QYNNWPPRYT FGQGTRLEIK RTVAAPSVFI FPPSDEQLKS GTASVVCLLN NFYPREAKVQ WKVDNALQSG N SQESVTEQ ...String: DIVMTQSPAT LSVSPGERAT LSCRASESVS SDLAWYQQKP GQAPRLLIYG ASTRATGVPA RFSGSGSGAE FTLTISSLQS EDFAVYYCQ QYNNWPPRYT FGQGTRLEIK RTVAAPSVFI FPPSDEQLKS GTASVVCLLN NFYPREAKVQ WKVDNALQSG N SQESVTEQ DSKDSTYSLS STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRG |
-Macromolecule #7: 17b Fab heavy chain
| Macromolecule | Name: 17b Fab heavy chain / type: protein_or_peptide / ID: 7 / Number of copies: 3 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 24.457387 KDa |
| Recombinant expression | Organism: Mammalia (mammals) |
| Sequence | String: EVQLVESGAE VKKPGSSVKV SCKASGDTFI RYSFTWVRQA PGQGLEWMGR IITILDVAHY APHLQGRVTI TADKSTSTVY LELRNLRSD DTAVYFCAGV YEGEADEGEY DNNGFLKHWG QGTLVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD Y FPEPVTVS ...String: EVQLVESGAE VKKPGSSVKV SCKASGDTFI RYSFTWVRQA PGQGLEWMGR IITILDVAHY APHLQGRVTI TADKSTSTVY LELRNLRSD DTAVYFCAGV YEGEADEGEY DNNGFLKHWG QGTLVTVSSA STKGPSVFPL APSSKSTSGG TAALGCLVKD Y FPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP K |
-Macromolecule #9: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 9 / Number of copies: 3 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 1.3 mg/mL |
|---|---|
| Buffer | pH: 8 |
| Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Support film - Material: CARBON / Support film - topology: HOLEY / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 20 sec. |
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 95 % / Chamber temperature: 298 K / Instrument: LEICA EM CPC |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 58.7 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.4 µm / Nominal defocus min: 0.8 µm |
| Sample stage | Cooling holder cryogen: NITROGEN |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
| Refinement | Space: REAL |
|---|---|
| Output model | ![]() PDB-9d90: |
Movie
Controller
About Yorodumi



Keywords
Human immunodeficiency virus 1
Homo sapiens (human)
Authors
United States, 2 items
Citation
























Z (Sec.)
Y (Row.)
X (Col.)





































FIELD EMISSION GUN

